Codiak Biosciences


    Grounded in breakthrough science and driven by medical need, Codiak BioSciences is advancing the frontiers of exosome research and manufacturing to create an entirely new class of therapeutics. Since its founding in 2015, Codiak has built a proprietary technology platform for exosome engineering and manufacturing that allows for precise therapeutic targeting, opening the door to the development of therapies to treat a diverse array of diseases that are currently difficult or impossible to treat using existing methodologies.